Clinical Trial Update: Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement [Phase 3]

View source ↗

Summary

Long-term observational study update following tanezumab studies in subjects undergoing total knee, hip, or shoulder replacement for osteoarthritis (Phase 3; co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-07-30